Pharma
PK/PD, dose-response, clinical trial modeling.
- Family — pharma
- Protocol count — 5
- Anchor — every call composes with
KO42+ up to three additional operators - Precision — ≤0.1% (HulyaPulse-synced)
Protocols
| ID | Name | Deploys as |
|---|---|---|
zeq-clinical-trial | ZeqClinicalTrial | contract zeq-clinical-trial |
zeq-dosing | ZeqDosing | contract zeq-dosing |
zeq-drug-interaction | ZeqDrugInteraction | contract zeq-drug-interaction |
zeq-formulation | ZeqFormulation | contract zeq-formulation |
zeq-pharmacovigilance | ZeqPharmacovigilance | contract zeq-pharmacovigilance |
Protocols are named formula bundles in the registry — they execute through the kernel, not through per-protocol routes.
Compose rule
Every protocol in this family composes registry operators — KO42 (the always-on time base) plus up to three more per call. Each transition fires its operator's closed-form solver; the result is phase-stamped to the Zeqond and returned with a ZeqProof. The verbatim equation the operator evaluated is recorded on the audit row as master_equation_block, so any result is re-derivable by hand.
Papers
- Zeq paper — https://doi.org/10.5281/zenodo.18158152
- Framework paper — https://doi.org/10.5281/zenodo.15825138
Middleware active. Kernel on the 1.287 Hz HulyaPulse. Awaiting next Zeqond.